Ten years after MIDAS: icodextrin lights and shadows

Contrib Nephrol. 2003:(140):76-81. doi: 10.1159/000071426.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Biocompatible Materials / adverse effects
  • Dialysis Solutions / pharmacokinetics
  • Dialysis Solutions / pharmacology*
  • Female
  • Glucans / pharmacokinetics
  • Glucans / pharmacology*
  • Glucose / pharmacokinetics
  • Glucose / pharmacology*
  • Humans
  • Icodextrin
  • Kidney Failure, Chronic / therapy
  • Male
  • Peritoneal Dialysis / adverse effects
  • Peritoneal Dialysis / methods*
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects
  • Peritoneal Dialysis, Continuous Ambulatory / methods
  • Peritonitis / prevention & control*
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Retrospective Studies
  • Safety
  • Sensitivity and Specificity
  • Time Factors
  • Treatment Outcome

Substances

  • Biocompatible Materials
  • Dialysis Solutions
  • Glucans
  • Icodextrin
  • Glucose